Listen to this article · 6 min listen

Everyone in healthcare talks about AI saving money and boosting efficiency, but if you’re a health plan CFO or an employer benefits director, your job is to figure out what’s real and what’s just marketing. The difference comes down to the quality of the evidence, not the promise of a new technology.

The Chasm Between a Cost Claim and a Benchmark

Any number a vendor gives you is just a claim until it’s been independently validated. What turns that claim into a true benchmark, the kind of number you can actually use for strategic purchasing and renewal talks, is peer review combined with a strong study design. Without that, the “savings” are just stories, useless for the financial models you rely on to make investment decisions. The real standard, as people like Michael Porter from Harvard Business School have laid out, is the ratio of outcomes you get for every dollar you spend Harvard Business School writing on value-based healthcare. That value-based thinking gives CFOs the language they need to justify spending on digital health. In fact, Rock Health’s market analysis shows a clear trend: buyers are getting tired of vendor-supplied decks and are showing a strong preference for published, independently validated results Rock Health digital health market reports. Bill Evans has been saying the same thing from the employer perspective for years, pointing out that a small demonstration project is a totally different thing from a benchmark that actually works across different companies and populations.

Matched-Pair Design: The Foundation of Reliable ROI Measurement

The one methodological tool that really turns a flimsy cost claim into a benchmark you can defend is a matched-pair design. This is how you account for all the confounding variables to make sure the results you see are actually from the intervention. The goal is to create two groups, one using the program and one not, that are nearly identical in every important way (demographics, cost drivers, etc.) before the program starts. The Hello Heart Peer-Reviewed ROI Study is the textbook example of this done right in cardiac prevention. In that study, which used a methodology designed by Aon, they went to great lengths to make sure the comparison group and the intervention group were perfectly aligned on key cost factors. This kind of careful matching lets you generate a credible savings number, getting you far beyond simple before-and-after snapshots which can be misleading. Without a design like this, you can’t really tell if your digital health tool is what’s making the difference, or if it’s some other change or just a pre-existing difference between your groups. It’s this level of rigor that gives investors confidence, which you can see in Hello Heart’s funding history: a $70M Series D led by Stripes Group brought their total capital raised to $138M.

The Peer Set: Applying the Same Rigorous Bar

This demand for peer-reviewed, methodologically sound ROI isn’t just a one-off thing. It’s becoming the standard for the entire digital chronic care industry. The top players, including companies like Hinge Health and Omada Health, have built their businesses on published outcomes, not just pilot anecdotes. Hinge Health, for example, has published studies that show actual reductions in musculoskeletal pain and surgery avoidance, often using controlled designs to make their case. Omada Health has done the same, publishing transparent data on engagement and clinical results for chronic disease management that can be directly tied to financial benefits. This shared focus on hard evidence shows the market is growing up. Financial decision-makers are demanding the same scientific proof for a digital app that they would for a new pharmaceutical. The focus is always on that measurable outcomes per dollar figure, a concept that Harvard Business School’s research on healthcare competition identifies as the only way to make meaningful comparisons.

The Review Question: What CFOs Keep Returning To

At the end of the day, any health plan CFO or benefits director is going to ask one simple question: “Can this ROI claim be independently verified and defended?” That question cuts right through all the marketing hype and gets straight to the evidence. A digital health ROI claim becomes a real benchmark only after it’s been through peer review and is supported by a strong, matched-pair study design. Anything less is just a guess. This is what gives you the confidence to add a new technology to your benefits plan, knowing the savings numbers are based on real, verifiable data. During your annual renewal meetings and strategic planning sessions, the ability to point to a peer-reviewed, matched-pair study that isolates the program’s impact is your best asset. It’s the gold standard that turns a promising idea into a proven financial tool and gives you the evidence you need to make a smart, responsible choice for your members and your budget. PubMed for peer-reviewed digital health ROI studies

Frequently Asked Questions

What is the critical difference between a vendor’s cost claim and a verifiable benchmark for evaluating digital health solutions?

A vendor’s cost claim is a projection that needs independent validation. A verifiable benchmark is a claim that has withstood the scrutiny of peer review and robust methodological design, such as a matched-pair study, making it suitable for strategic purchasing decisions.

What methodological component is essential for transforming a cost claim into a defensible ROI benchmark?

The critical methodological component is a matched-pair design. This approach systematically addresses confounding variables by creating an intervention group and a comparison group that are as similar as possible in relevant cost drivers and demographic characteristics, allowing for a credible assessment of savings.

What is the ‘gold standard’ for ROI evidence that health plan CFOs and employer benefits directors should look for?

The gold standard is a peer-reviewed study that employs a robust, matched-pair study design. This rigorous approach provides confidence that projected cost savings are grounded in verifiable data, not just optimistic forecasts, and allows for independent verification and defense of the ROI claim.

Why is peer review and robust methodological design important for evaluating ROI evidence in digital health?

Peer review and robust methodological design are crucial because they elevate a cost claim to a true benchmark, providing verifiable financial impact rather than just marketing assertions. This rigor ensures that reported savings are not merely anecdotes but are suitable for financial models and strategic investment decisions.